AKAP9 anticorps (AA 71-191) (FITC)
AKAP9
Reactivité: Humain
ELISA
Hôte: Lapin
Polyclonal
FITC
N° du produit ABIN6087102
-
-
Antigène
Voir toutes AKAP9 Anticorps
-
AKAP9
(A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
-
Épitope
-
AA 71-191
-
Reactivité
-
Humain
-
Hôte
-
Lapin
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp AKAP9 est conjugé à/à la FITC
-
Application
-
ELISA
-
Purification
-
Protein G
-
Immunogène
-
Recombinant Human A-kinase anchor protein 9 protein (71-191AA).
-
Isotype
-
IgG
-
Top Product
-
Discover our top product AKAP9 Anticorps primaire
-
-
-
Indications d'application
-
Optimal working dilution should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
0.01 M PBS, pH 7.4, 0.03 % Proclin-300 and 50 % Glycerol.
-
Agent conservateur
-
ProClin
-
Précaution d'utilisation
-
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
-
-20 °C,-80 °C
-
Stockage commentaire
-
Aliquot and store at -20 °C or -80 °C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
-
-
Antigène
-
AKAP9
(A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
-
Autre désignation
-
AKAP9 (AKAP9 Produits)
-
Synonymes
-
anticorps AKAP-9, anticorps AKAP350, anticorps AKAP450, anticorps CG-NAP, anticorps HYPERION, anticorps LQT11, anticorps MU-RMS-40.16A, anticorps PPP1R45, anticorps PRKA9, anticorps YOTIAO, anticorps 5730481H23Rik, anticorps AW545847, anticorps C79026, anticorps mKIAA0803, anticorps Gisp, anticorps Yotiao, anticorps AKAP9, anticorps wu:fj02h02, anticorps prka9, anticorps yotiao, anticorps akap350, anticorps akap450, anticorps hyperion, anticorps AKAP120, anticorps A-kinase anchoring protein 9, anticorps A kinase (PRKA) anchor protein (yotiao) 9, anticorps A kinase (PRKA) anchor protein 9, anticorps A-kinase anchoring protein AKAP120, anticorps AKAP9, anticorps Akap9, anticorps akap9, anticorps CpipJ_CPIJ006715, anticorps CpipJ_CPIJ017436
-
ID gène
-
10142
-
UniProt
-
Q99996
-
Pathways
-
M Phase, SARS-CoV-2 Protein Interactome
-